Hyperinsulinism due to INSR deficiency: A Patient Guide

Hyperinsulinism due to INSR deficiency is a rare genetic condition that fundamentally changes how the body processes energy. At its core, the condition is caused by mutations in the INSR gene, which provides the instructions for building the insulin receptor ^[1]. These receptors normally act as “locks” on the surface of cells; when insulin (the “key”) turns the lock, the cell opens to absorb sugar from the blood for fuel. When these receptors have altered signaling, the body’s cells become profoundly resistant to insulin’s signal, leading to a complex and often contradictory set of symptoms ^[2].

Because the cells are “hungry” for energy but cannot receive it, the body compensates by overproducing insulin to extreme levels. This leads to a medical paradox: the patient has enough insulin to fuel many people, yet their blood sugar may remain high because the insulin cannot work effectively. At the same time, this compensatory hyperinsulinemia—combined with specific residual receptor function—can interfere with the liver’s ability to release sugar during fasts or cause rapid post-meal drops. This results in hypoglycemia (dangerous low blood sugar) in some patients ^[3][4]. Navigating this confusing combination of severe insulin resistance and possible hypoglycemia is the central challenge of the condition.

The impact of INSR deficiency exists on a broad severity spectrum of overlapping phenotypes, not mandatory stages that a person must progress through. On the most severe end is Donohue syndrome, which is typically identified in infancy and involves significant growth and developmental challenges. Rabson-Mendenhall syndrome represents an intermediate form with distinctive physical changes and childhood-onset diabetes. On the milder end of the spectrum is Type A insulin resistance, which is often first noticed around puberty and may involve hormonal imbalances. While these names help doctors categorize the condition, they represent a continuum of clinical presentations driven by the underlying genetics ^[5][6].

Managing life with INSR deficiency requires a highly individualized approach. Because standard diabetes treatments can sometimes need careful individualization, care teams use specialized strategies to stabilize the metabolic system. This includes dietitian-supervised nutritional planning to prevent fasting lows and the use of targeted off-label medications. While the complexity of the condition can be daunting, a dedicated team of specialists—from endocrinologists to cardiologists—can help families create a stable environment that supports growth, development, and long-term health ^[7][8].